The legacy of pharmacogenetics and potential applications

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 479, Issue 1-2, 2001, Pages 1-18

  Weber, Wendell W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Drug discovery; Drug susceptibility profiles; Personalized drug therapy; Pharmacogenetics; Pharmacogenomics; Rational drug design

Indexed keywords

ALDEHYDE DEHYDROGENASE; ANDROGEN; ANTIDEPRESSANT AGENT; ARYLDIALKYLPHOSPHATASE; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; DRUG METABOLIZING ENZYME; ESTROGEN; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; GROWTH HORMONE; INSULIN RECEPTOR; IODIDE; MINERALOCORTICOID; POTASSIUM ION; RETINOIC ACID; RGS PROTEIN; RYANODINE RECEPTOR; SODIUM ION; SULFATE; SULFONYLUREA; SUXAMETHONIUM; THIOPURINE METHYLTRANSFERASE; UNINDEXED DRUG; VASOPRESSIN; VITAMIN D;

BIODIVERSITY; CELLULAR DISTRIBUTION; CHEMOTAXIS; CYSTIC FIBROSIS; DRUG DESIGN; DRUG RESEARCH; DRUG RESPONSE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME POLYMORPHISM; GENETIC POLYMORPHISM; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MISSENSE MUTATION; NONHUMAN; PERIODONTITIS; PHARMACOGENETICS; PHARMACOGENOMICS; POPULATION; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN VARIANT; REVIEW; THROMBOPHILIA; VITAMIN D RESISTANT RICKETS;

EID: 0035828190     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00151-8     Document Type: Article

References (70)

1. The double helix revisited
2. Genomics: Journey to the center of biology
3. Populations and genetic polymorphisms
4. Pharmacogenetics
5. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome
6. Pharmacogenetic - Receptors
7. Flutamide withdrawal syndrome: Its impact on clinical trials in hormone-refractory prostate cancer
8. 24→18) in the androgen receptor gene in human prostate cancer
9. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy
10. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
11. Resistance to HIV-1 infection in Caucasian individual bearing mutant alleles of the CCR-5 chemokine receptor gene
12. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene
13. Mutations in a dominant-negative isoform correlate with phenotype in inherited cardiac arrhythmias
14. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
15. Single nucleotide polymorphisms of the N-formyl peptide receptor in localized juvenile periodontitis
16. Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
17. Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
18. Recent advances in understanding the molecular basis of congenital hypothyroidism
19. Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity
20. The superfamily of heptahelical receptors
21. Nomenclature for human CYP2D6 alleles
22. Genetic polymorphism of thiopurine S-methyltransferase: Molecular mechanisms and clinical importance
23. Metabolic, molecular genetic and toxicological aspects of the acetylation polymorphism in inbred mice
24. The AH-receptor genetics, structure and function
25. Insertion DNA sequences into the human chromosomal β-globin locus by homologous recombination
26. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
27. High-fidelity gene targeting in embyronic stem cells by using sequence replacement vectors
28. Inducible gene targeting in mice
29. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter
30. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains
31. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice
32. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter
33. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat
34. DNA variation and the future of human genetics
35. Technologies for detecting genetic polymorphisms in pharmacogenomics
36. Sequence variation in genes and genomic DNA: Methods for large-scale analysis
37. Genomics, gene expression and DNA arrays
38. Clinical, genetic, and pharmacogenetic applications of the Invader assay
39. Pharmacogenetic testing
40. Regulation of cytochromes P450 during inflammation and infection
41. Physiological and pathophysiological regulation of cytochrome P450
42. Elucidation of the common 'intermediate metabolizer' genetic basis of the phenotype for drug oxidation by CYP2D6
43. Validation of the five-drug "Pittsburgh cocktail" approach for assessment of selective regulation of drug-metabolizing enzymes
44. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry
45. Advances in understanding drug metabolism and its contribution to variability in patient responses
46. The alchemists
47. Drug shown to shrink tumors in type of breast cancer by targeting gene defect
48. Tailoring drugs to fit the genes
49. The genome is mapped. Now what?
50. Newfound protein touches off race for new therapies
51. When gene sequencing becomes a fact of life. Test helps doctors find best AIDS drugs
52. Structural proteomics of an archaeon
53. Guilt-by-association goes global
54. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae
55. Printing proteins as microarrays for high-throughput function determination
56. Structural mechanism for STI-571 inhibition of abselson tyrosine kinase
57. Design of allele-specific inhibitors to probe protein kinase signaling
58. A chemical switch for inhibitor-sensitive alleles of any protein kinase
59. A chemistry set for life
60. Signals to move cells
61. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction
62. Function of PI3Kγ in thymocyte development, T cell migration, and neutrophil migration
63. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation
64. Distinct (PI)3Ks mediate mitogenic signalling and cell migration in macrophages
65. Emerging roles for RGS proteins in cell signaling
66. The regulator of G protein signaling family
67. RGS proteins: Novel multifunctional drug targets
68. Clinical pharmacogenomics: Applications in pharmaceutical R&D
69. Exploiting human genetic variation in drug discovery and development